Hypoxia enhances ligand-occupied androgen receptor activity

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Androgen receptor (AR) signaling is a key driver in prostate cancer development and progression.
• Hypoxia, a common feature in solid tumors, can influence cancer cell behavior.
• The interplay between hypoxia and AR signaling in prostate cancer remains incompletely understood.

Purpose of the Study:

• To investigate the combined effects of dihydrotestosterone (DHT) and hypoxia on AR-mediated transactivation in prostate cancer cells.
• To determine if hypoxia potentiates AR transcriptional activity induced by DHT.
• To examine the impact of combined DHT and hypoxia on VEGF secretion.

Main Methods:

• Utilized LNCaP prostate cancer cells.
• Introduced AR-responsive reporter plasmids to measure AR-mediated transactivation.
• Assessed AR and HIF-1α expression levels.
• Measured VEGF secretion under various treatment conditions (DHT, hypoxia, combined).

Main Results:

• Hypoxia alone did not induce a detectable AR-mediated response without DHT.
• DHT-induced AR transcriptional activity was significantly enhanced by hypoxia or ectopic HIF-1α expression.
• Combined hypoxia and DHT treatment led to enhanced VEGF secretion compared to individual treatments.
• These effects were independent of increased AR or HIF-1α expression.

Conclusions:

• Hypoxia potentiates DHT-induced AR transcriptional activity in prostate cancer cells.
• The combination of hypoxia and DHT stimulates VEGF secretion, potentially promoting angiogenesis.
• Hypoxia may activate unknown factors that enhance AR signaling pathways, contributing to prostate cancer progression.